🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Epilepsy; Seizure

Improving Diagnostics and Care After First Seizure NCT06814665n/a1 site📍 Bergen Haukeland University Hospital A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) NCT05716100Phase 398 sites📍 Little Rock📍 Downey📍 Los Angeles Xenon Pharmaceuticals Inc. · Tests: XEN1101, Placebo A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures NCT04715646Phase 336 sites📍 Hawthorne📍 Durham📍 Leuven UCB Biopharma SRL · Tests: Brivaracetam Ear-Seizure Detection (EarSD) Study NCT06598189NA2 sites📍 Worcester📍 Worcester Felicia Chu · Tests: Ear-SD, Electroencephalogram A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety NCT07019922Phase 310 sites📍 San Diego📍 Aurora📍 Chicago Praxis Precision Medicines · Tests: 1mg elsunersen, 0.5mg elsunersen Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG) NCT05944692n/a2 sites📍 Phoenix📍 Boston CREmedical · Tests: Tripolar electroencephalography A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures NCT05667142Phase 3138 sites📍 Mobile📍 Phoenix📍 Tucson Xenon Pharmaceuticals Inc. · Tests: XEN1101, Placebo Effects of Recorded Music on Clinical and EEG Seizure Activity NCT05289934NA1 site📍 Baltimore Johns Hopkins University · Tests: Music Stimuli Prospective Regional Epilepsy Database NCT04559919n/a3 sites📍 Borås📍 Gothenburg📍 Gothenburg Sahlgrenska University Hospital · Tests: Seizure status, Tests, Epilepsy, Demographics and psychosocial, Health care Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures NCT07594119Phase 313 sites📍 Huntsville📍 Bentonville📍 Colorado Springs Rapport Therapeutics Inc. · Tests: RAP-219, RAP-219, Placebo Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain NCT06716801n/a1 site📍 Paris Aziende Chimiche Riunite Angelini Francesco S.p.A · Tests: Cenobamate Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy NCT05518578Phase 210 sites📍 Jacksonville📍 Miami📍 Randwick Supernus Pharmaceuticals, Inc. · Tests: SPN-817 Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment NCT07116330n/a3 sites📍 Borås📍 Gothenburg📍 Malmö Sahlgrenska University Hospital · Tests: Vascuar risk factor screening (blood pressure, medical history, BMI, laboratory tests) An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures NCT06908356Phase 211 sites📍 Phoenix📍 Miami Lakes📍 Bethesda Praxis Precision Medicines · Tests: 30mg PRAX-628 Human Epilepsy Genetics--Neuronal Migration Disorders Study NCT00041600n/a1 site📍 Boston Harvard University Faculty of Medicine Status Epilepticus Population Study (STEPS) NCT04204863n/a2 sites📍 Aarau📍 Basel University Hospital, Basel, Switzerland · Tests: collection of patient data An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome NCT05066217Phase 371 sites📍 Little Rock📍 Orange📍 Miami Epygenix · Tests: Clemizole HCl, Placebo Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis NCT04421846NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3), Blood sampling, cerebrospinal … Telephone-Based Support Programs for People With Epilepsy NCT05082181NA1 site📍 New York NYU Langone Health · Tests: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts), BOOST (Bringing Out Our Strength Together) A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome NCT04462770Phase 368 sites📍 Birmingham📍 Little Rock📍 Los Angeles Epygenix · Tests: Clemizole HCl, Placebo Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) NCT05135091Phase 335 sites📍 Birmingham📍 Phoenix📍 Tucson Neurona Therapeutics · Tests: NRTX-1001, NRTX-1001, Sham Comparator Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults NCT05219617Phase 371 sites📍 Palo Alto📍 Jacksonville📍 Orlando SK Life Science, Inc. · Tests: Carisbamate SeizEAR Safety Study NCT07088835NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: SeizEAR A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome NCT07675746EARLY Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: RC001 injection-Dose Escalation Cohort, RC001 injection-Fixed Dose Cohort Early Post-Traumatic Seizures Prevention Trial (E-PTS Trial) NCT07072624Phase 43 sites📍 Chandigarh📍 Jodhpur📍 Lucknow All India Institute of Medical Sciences, Jodhpur · Tests: Phenytoin, Levetiracetam, Placebo Tumor Related Epilepsy NCT02639325n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Infrared Photobiomodulation in Humans With Epilepsy NCT07145489NA1 site📍 Boston Beth Israel Deaconess Medical Center · Tests: photobiomodulation A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome NCT05419492Phase 1, Phase 214 sites📍 San Francisco📍 Aurora📍 Miami Encoded Therapeutics · Tests: ETX101 A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures NCT06967012Phase 41 site📍 Nantong Affiliated Hospital of Nantong University · Tests: Oral Zonisamide Therapy Retraining and Control Therapy (ReACT) R33 Phase NCT06007053NA1 site📍 Birmingham University of Alabama at Birmingham · Tests: ReACT, Supportive Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy